WASHINGTON, D.C. (September 18, 2020)—The Office of Inspector General (OIG) of the Department of Health and Human Services conducted an audit to determine whether the Centers for Medicare & Medicaid Services (CMS) ensured that MACs and QICs reviewed appealed extrapolated overpayments consistently and in a manner that conforms with existing CMS requirements.

WASHINGTON, D.C. (July 24, 2020)—The Centers for Medicare & Medicaid Services (CMS) could have saved $192 million by targeting home health claims for review with visits slightly above the threshold that triggers a higher Medicare payment, according to a new report from the Office of Inspector General (OIG) of the Department of Health & Human Services.

WASHINGTON, D.C. (March 31, 2019)—Monday evening, the Centers for Medicare & Medicaid Services (CMS) released an Interim Final Rule (IFR) addressing a range of healthcare issues related to the novel coronavirus (COVID-19) outbreak. AAHomecare performed an initial analysis of the IFR that indicates that priority policy recommendations from the HME industry have been included, except for the delay of competitive bidding.

WASHINGTON, D.C. (October 3, 2019)—The Centers for Medicare & Medicaid (CMS) announced that the next state to participate in the Review Choice Demonstration (RCD) is Texas and it will begin on Dec. 2, 2019. CMS also indicated that implementation of RCD in the remaining states of North Carolina and Florida is expected to begin on March 30, 2020, as CMS is pausing implementation to allow for the transition to PDGM which begins on Jan. 1, 2020.

WASHINGTON, D.C. (June 18, 2019)—Performant, the Recovery Audit Contractor (RAC), has received approval to audit blood glucose test or reagent strips (A4253) as of June 14, 2019. This is a national complex review and the description of the review states: “The quantity of glucose test strips (A4353) that are covered depends upon the usual medical needs of the diabetic patient.